Back
Madrigal Pharmaceuticals Stock Price Chart
Buy
54
MDGL
Madrigal Pharmaceuticals
Last Price:
220.06
Seasonality Move:
-8.39%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is relatively stagnant and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
Madrigal Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 211.46 | Buy |
| 20-day SMA: | 211.56 | Buy |
| 50-day SMA: | 234.2 | Sell |
| 200-day SMA: | 201.75 | Buy |
| 8-day EMA: | 214.56 | Buy |
| 20-day EMA: | 216.55 | Buy |
| 50-day EMA: | 224.38 | Sell |
| 200-day EMA: | 215.91 | Buy |
Madrigal Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.21 | Sell |
| Relative Strength Index (14 RSI): | 50.69 | Buy |
| Chaikin Money Flow: | 130228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.16 - 225.52) | Buy |
| Bollinger Bands (100): | (211.12 - 251.34) | Sell |
Madrigal Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
- Madrigal Pharmaceuticals share price is 220.06 while MDGL 8-day simple moving average is 211.46, which is a Buy signal.
- The stock price of MDGL is 220.06 while Madrigal Pharmaceuticals 20-day SMA is 211.56, which makes it a Buy.
- Madrigal Pharmaceuticals 50-day simple moving average is 234.20 while MDGL share price is 220.06, making it a Sell technically.
- MDGL stock price is 220.06 and Madrigal Pharmaceuticals 200-day simple moving average is 201.75, creating a Buy signal.
MDGL Technical Analysis vs Fundamental Analysis
Buy
54
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a Buy
The current Madrigal Pharmaceuticals [MDGL] share price is $220.06. The Score for MDGL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
4.69B
Price in USD:
220.06
Share Volume:
236.44K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
302.68
52-Week Low:
119.76
Buy
54
Madrigal Pharmaceuticals (MDGL)
is a Buy
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?
The Madrigal Pharmaceuticals stock price is 220.06 USD today. -
Will MDGL stock go up or go down?
Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Madrigal Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is not overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
- Madrigal Pharmaceuticals share price is 220.06 while MDGL 8-day exponential moving average is 214.56, which is a Buy signal.
- The stock price of MDGL is 220.06 while Madrigal Pharmaceuticals 20-day EMA is 216.55, which makes it a Buy.
- Madrigal Pharmaceuticals 50-day exponential moving average is 224.38 while MDGL share price is 220.06, making it a Sell technically.
- MDGL stock price is 220.06 and Madrigal Pharmaceuticals 200-day simple moving average is 215.91, creating a Buy signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
- MDGL Moving Average Covergence Divergence (MACD) indicator is -4.21, suggesting Madrigal Pharmaceuticals is a Sell
- Madrigal Pharmaceuticals Relative Strength Index (RSI) is 50.69, which suggest Madrigal Pharmaceuticals is overbought
- The Bollinger Bands (25) for Madrigal Pharmaceuticals is (203.16 - 225.52), which suggest Madrigal Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Madrigal Pharmaceuticals is (211.12 - 251.34), which suggest Madrigal Pharmaceuticals is a Sell
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.